LYNN HEALTH SCIENCE INSTITUTE IS LOOKING FOR PARTICIPANTS
PAID CLINICAL TRIAL
- Lasting up to 60 weeks
YOU MAY BE ELIGIBLE TO PARTICIPATE IF YOU MEET THE FOLLOWING CRITERIA:
-
Are 12-65 yrs. of age
-
Have a confirmed diagnosis of sickle cell disease
?>
» Studies » Forma Sickle Cell
» Studies » Forma Sickle CellForma Sickle Cell
Purpose Of Study
The purpose of this study is to learn more about etavopivat ( is an experimental drug that may help treat sickle cell disease by acting to a lower rate of red blood cell sickling) and to see if it is safe and helpful for people who have sickle cell disease.
LEARN MORE ABOUT PARTICIPATING IN A CLINICAL TRIAL
Lynn Institute is a leader in introducing new medications to the market through our clinical trials program. Visit our Participation Information page for Frequently Asked Questions, to see current clinical trials listed, and to find out where each trial is being conducted.
Find out More About Our Participation Program
Participation Information